![](https://www.Immune-System-Research.com/"wp-content/uploads"/2023/03/Tirzepatide-LY3298176-is-a-Dual-GIP-and-GLP-1-Receptor-Agonist-for-Type-2-Diabetes-Research-2023-0308.jpg)
Type 2 Diabetes Mellitus (T2DM) is one of the most common metabolic disorders worldwide. Furthermore, cardiovascular disease (CVD) is the…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2023/03/Empagliflozin-BI-107730-is-a-Selective-SGLT-2-Inhibitor-for-Type-2-Diabetes-Research-2023-0301.jpg)
Diabetes has a major impact on the global human population. Generally, blood glucose control is the major method of diabetes…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2023/02/Midaglizole-is-a-Potent-α2-Adrenoceptor-Antagonist-with-a-Hypoglycemic-Activity-2023-0213.jpg)
α2-adrenoceptor is a G protein-coupled receptor (GPCR) associated with the Gi heterotrimeric G-protein. Besides, the α2-adrenoceptor not only inhibits the…